Clinical Registry for PFO Closure

The purpose of this clinical registry is to allow access to a new PFO occluder device for those patients who have had at least two strokes and who have failed drug therapy.  Overall, 6000 patients will be recruited for this study. At Rush University Medical Center, we expect to enroll approximately 10 patients.

You may be eligible for this study if you:

• Have PFO confirmed by echocardiography
• Have suffered from at least two strokes while on antiplatelet therapy

You are not eligible for this study if you:

• Have an INR range greater than 2-3
• Have known blood coagulation disorders 

This is a partial list of eligibility and exclusion criteria. To determine if you are eligible to participate, please call the contact phone number provided. If you choose to respond by e-mail, please refer to the title of the study in your correspondence.